Association between polymorphisms of folate- and methionine-metabolizing enzymes and susceptibility to malignant lymphoma

Blood

Volumn 97, Issue 10, 2001, Pages 3205-3209

  Matsuo, Keitaro ^a,b   Suzuki, Ritsuro ^a,b   Hamajima, Nobuyuki ^a,b   Ogura, Michinori ^a,b   Kagami, Yoshitoyo ^a,b   Taji, Hirofumi ^a,b   Kondoh, Eisei ^a,b   Maeda, Satoko ^a,b   Asakura, Shoji ^a,b   Kaba, Sadayuki ^a,b   Nakamura, Shigeo ^a,b   Seto, Masao ^a,b   Morishima, Yasuo ^a,b   Tajima, Kazuo ^a,b  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); DOUBLE STRANDED DNA; FOLIC ACID; METHIONINE; METHIONINE SYNTHASE;

ADULT; AGED; ALLELE; ARTICLE; DNA METHYLATION; DNA POLYMORPHISM; DNA SYNTHESIS; ENZYME ACTIVITY; ENZYME METABOLISM; FEMALE; GENE MUTATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0035874520     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V97.10.3205     Document Type: Article

References (36)

1. Kuppers R, Klein U, Hansmann ML, Rajewsky K. Cellular origin of human B-cell lymphomas. N Engl J Med. 1999;341:1520-1529.
2. Vanesse GJ, Concannon P, Willerford DM. Regulated genomic instability and neoplasia in the lymphoid lineage. Blood. 1999;94:3997-4010.
3. Zingg JM, Jones PA. Genetic and epigenetic aspects of DNA methylation on genome expression, evolution, mutation and carcinogenesis. Carcinogenesis. 1997;18:869-882.
4. Dreyling MH, Bullinger L, Ott G, et al. Alterations of the cyclin D1/p16-pRB pathway in mantle cell lymphoma. Cancer Res. 1997;57:4608-4614.
5. Shane B. Folate metabolism. In: Picciano MF, Sokstad ELR, Gregory JF, eds. Folic Acid Metabolism in Health and Disease. New York, NY: Wiley-Liss; 1990:65-78.
6. Goyette P, Summers JS, Milos R, et al. Human methylenetetrahydrofolate reductase: isolation of cDNA mapping and mutation identification. Nat Genet. 1994;7:195-200.
7. Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrefolate reductase. Nat Genet. 1995;10:111-113.
8. van der Put NMJ, Gabreels F, Stevens EMB, et al. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am J Hum Genet. 1998;26:1044-1051.
9. Blount BC, Mack MM, Wehr CM, et al. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implication for cancer and neuronal damage. Proc Natl Acad Sci U S A. 1997;94:3290-3295.
10. Dianov GL, Timchenko TV, Sinitsina OI, Kuzminov AV, Medvedev OA, Salganik RI. Repair of uracil residues closely space on the opposite strands of plasmid DNA results in double-strand break and deletion formation. Mol Gen Genet. 1991;225:448-452.
11. van der Put NMJ, Steegers-Theunissen RPM, Frosst P, et al. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet. 1995;346:1071-1072.
12. Morita H, Taguchi J, Kurihara H, et al. Genetic polymorphism of 5, 10 methylenetetrahydrofolate reductase (MTHFR) as a risk factor for coronary artery disease. Circulation. 1997;95:2032-2036.
13. Kang SS, Wong PW, Susmano A, Sora J, Norusis M, Ruggle N. Thermolabile methylenetetrahydrofolate reductase: an inherited risk factor for coronary artery disease. Am J Hum Genet. 1991;48: 536-545.
14. Markus HS, Ali N, Swaminathan R, Sankaralingam A, Molloy J, Powell J. A common polymorphism in the methylenetetrahydrofolate reductase gene, homocysteine, and ischemic cerebrovascular disease. Stroke. 1997;28:1739-1743.
15. Morita H, Kurihara H, Tusbaki S, et al. Methylenetetrahydrofolate reductase gene polymorphism and ischernic stroke in Japanese. Arterioscler Thromb Vasc Biol. 1998;18:1465-1469.
16. Fujimura H, Kawasaki T, Sakata T, et al. Common C677T polymorphism in the methylenetetrahydrofolate reductase gene increases the risk for deep vein thrombosis in patients with predisposition of thrombophilia. Thromb Res. 2000;98:1-8.
17. Cattaneo M, Tsai MY, Bucciarelli P, et al. A common mutation in the methylenetetrahydrofolate reductase gene (C677T) increases the risk for deep-vein thrombosis in patients with mutant factor V (factor V:Q506). Arterioscler Thromb Vasc Biol. 1997;17:1662-1666.
18. Ma J, Stampfer MJ, Giovannucci E, et al. Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res. 1997;57:1098-1102.
19. Slattery ML, Potter JD, Samowittz W, Schaffer D, Leppert M. Methylenetetrahydrofolate reductase, diet, and risk of colon cancer. Cancer Epidemiol Biomarkers Prev. 1999;8:513-518.
20. Estellar M, Garcia A, Martinez-Palones JM, Xercavins J, Reventos J. Germ line polymorphisms in cytochrome-P450 1A1 (C4887 CYP1A1) and methylenetetrahydrofolate reductase (MTHFR) genes and endometrial cancer susceptibility. Carcinogenesis. 1997;18:2307-2311.
21. Skibola CF, Smith MT, Kane L, et al. Polymorphisms in the methyleneletrahydrofolate reductase gene are associated with susceptibility to acute leukemia in adults. Proc Natl Acad Sci U S A. 1999;96:12810-12815.
22. Leclerc D, Campeau E, Goyette P, et al. Human methionine synthase: cDNA cloning and identification of mutations in patients of the cbIG complementation group of folate/cobalamin disorders. Hum Mol Genet. 1996;5:1867-1874.
23. Harmon DL, Shields DC, Woodside JV, et al. Methionine synthase D919G polymorphism is a significant but modest determinant of circulating homocysteine concentrations. Genet Epidemiol. 1999;17:298-309.
24. Ma J, Stampfer MJ, Christensen B, et al. A polymorphism of the methionine synthase gene: association with plasma folate, vitamin B12, homocysteine, and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev. 1999;8:825-829.
25. Morita H, Kurihara H, Sugiyama T, et al. Polymorphism of the methionine synthase gene association with homocysteine metabolism and late-onset vascular diseases in the Japanese population. Arterioscler Thromb Vasc Biol. 1999;19:298-302.
26. Chen J, Giovannucci E, Kelsey K, et al. A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer. Cancer Res. 1996;56:4862-4864.
27. Franco RF, Morelli V, Lourenco D, et al. A second mutation in the methylenetetrahydrofolate reductase gene and the risk of venous thrombotic disease. Br J Haematol. 1999;105:556-559.
28. van der Put NMJ, van der Molen EF, Kluitmans LAJ, et al. Sequence analysis of the coding region of human methionine synthase: relevance to hyperhomocysteinaemia in neural-tube defects and vascular disease. Q J Med. 1997;90:511-517.
29. Chen LH, Liu ML, Hwang HY, Chen LS, Korenberg J, Shane B. Human methionine synthase: cDNA cloning, gene localization, and expression. J Biol Chem. 1997;272:3628-3634.
30. Hagmar L, Brøgger A, Hansteen IL, et al. Cancer risk in humans predicted by increased levels of chromosomal aberrations in lymphocytes: Nordic study group on the health risk of chromosome damage. Cancer Res. 1994;54:2919-2922.
31. Møller MB, Ino Y, Gerdes AM, SkJødt K, Louis DN, Pedersen NT. Aberration of the p53 pathway components p53, MDM2 and CDKN2A appear independent in diffuse large B cell lymphoma. Leukemia. 1999;13:453-459.
32. Baur AS, Shaw P, Burri N, Delacretaz F, Bosman FT, Chaubert P. Frequent methylation silencing of p15INK4b (MTS2) and p16INK4a (MTS1) in B-cell and T-cell lymphomas. Blood, 1999;94:17731781.
33. Gonzalez M, Mateos MV, Garcia-Sanz R, et al, De novo methylation of tumor suppressor gene p16/INK4a is a frequent finding in multiple myeloma patients at diagnosis. Leukemia, 2000;14:183-187.
34. Hagmar L, Brøgger A, Hansteeen IL, et al. Cancer risk in humans predicted by increased levels of chromosomal aberrations in lymphocytes: Nordic study group on the health risk of chromosomal damage. Cancer Res. 1994;54:2919-2922.
35. Bonassi S, Abbondandolo A, Camurri L, et al. Are chomosome aberrations in circulating lymphocytes predictive of future cancer onset in humans? Cancer Genet Cytogenet. 1995;79:133-135.
36. Berry RJ, Li Z, Erickson JD, et al. Prevention of neural-tube defects with folic acid in China. N Engl J Med. 1999;341:1485-1490.